Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A new paradigm in human genetics is high frequencies of inter-individual variations in copy numbers of specific genomic DNA segments. Such common copy number variation (CNV) loci often contain genes engaged in host-environment interaction including those involved in immune effector functions. DNA sequences within a CNV locus often share a high degree of identity but beneficial or deleterious polymorphic variants are present among different individuals. Thus, common gene CNVs can contribute, both qualitatively and quantitatively, to a spectrum of phenotypic variants. In this review we describe the phenotypic and genotypic diversities of complement C4 created by copy number variations of RCCX modules (RP-C4-CYP21-TNX) and size dichotomy of C4 genes. A direct outcome of C4 CNV is the generation of two classes of polymorphic proteins, C4A and C4B, with differential chemical reactivities towards peptide or carbohydrate antigens, and a range of C4 plasma protein concentrations (from 15 to 70 mg/dl) among healthy subjects. Deliberate molecular genetic studies enabled development of definitive techniques to determine exact patterns of RCCX modular variations, copy numbers of long and short C4A and C4B genes by Southern blot analyses or by real-time quantitative PCR. It is found that in healthy European Americans, the total C4 gene copy number per diploid genome ranges from 2 to 6: 60.8% of people with four copies of C4 genes, 27.2% with less than four copies, and 12% with more than four copies. Such a distribution is skewed towards the low copy number side in patients with systemic lupus erythematosus (SLE), a prototypic autoimmune disease with complex etiology. In SLE, the frequency of individuals with less than four copies of C4 is significantly increased (42.2%), while the frequency of those with more than four copies is decreased (6%). This decrease in total C4 gene copy number in SLE is due to increases in homozygous and heterozygous deficiencies of C4A but not C4B. Therefore, it is concluded that lower copy number of C4 is a risk factor for and higher gene copy number of C4 is a protective factor against SLE disease susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892 · cited 2×
“ca/variation/, build 36, hg18), a total of 14,724 loci show genomic alterations that involve segments of DNA 1 1 kb (Iafrate et al., 2004; Sebat et al., 2004; Redon et al., 2006; Eichler et al., 2007; Lupski, 2007; Wong et al., 2007).”
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795 · cited 1×
“One is de novo that is detectable in some neurologic disease patients such as those with autism or schizophrenia (Sebat et al., 2007; Sutrala et al., 2007; Cantor and Geschwind, 2008; Marshall et al., 2008).”
Structural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815 · cited 1×
“One is de novo that is detectable in some neurologic disease patients such as those with autism or schizophrenia (Sebat et al., 2007; Sutrala et al., 2007; Cantor and Geschwind, 2008; Marshall et al., 2008).”
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
A comparison of the properties of two classes, C4A and C4B, of the human complement component C4
Law, S. K., Dodds, A. W., & Porter, R. R. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02052.x · Cited by 303 · cited 2×
“…group) and glycerol (with hydroxyl group) using purified C4A and C4B proteins showed that activated C4A binds to glycine effectively and forms an amide bond, while activated C4B binds to glycerol very efficiently and forms an ester linkage with targets (Isenman and Young, 1984; Law et al., 1984).”
Yu, C. Y., Belt, K. T., Giles, C. M., Campbell, R. D., & Porter, R. R. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04582.x · Cited by 221
Self-citationBlanchong, C. A., Zhou, B., Rupert, K. L., Chung, E. K., Jones, K. N., Sotos, J. F., Zipf, W. B., Rennebohm, R. M., & Yu, C. Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2183 · Cited by 187 · cited 3×
“…in some patients with Ehlers-Danlos syndrome or CAH who acquired a 120-bp deletion spanning intron 35 to exon 36 into TNXB from TNXA via a recombination or a gene conversion-like event (Collier et al., 1993; Rupert et al., 1999; Yang et al., 1999; Blanchong et al., 2000; Schalkwijk et al., 2001).”
Self-citationYang, Z., Mendoza, A. R., Welch, T. R., Zipf, W. B., & Yu, C. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12147 · Cited by 184 · cited 3×
“…in some patients with Ehlers-Danlos syndrome or CAH who acquired a 120-bp deletion spanning intron 35 to exon 36 into TNXB from TNXA via a recombination or a gene conversion-like event (Collier et al., 1993; Rupert et al., 1999; Yang et al., 1999; Blanchong et al., 2000; Schalkwijk et al., 2001).”
InfluentialSelf-citationSchizophrenia: Genome, Interrupted
Cantor, R. M., & Geschwind, D. H. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.007 · Cited by 28 · cited 1×
“One is de novo that is detectable in some neurologic disease patients such as those with autism or schizophrenia (Sebat et al., 2007; Sutrala et al., 2007; Cantor and Geschwind, 2008; Marshall et al., 2008).”
Cited by
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Crow, M. K. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223741 · Cited by 398
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Genes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
Lao, Q., Jardin, M. D., Jayakrishnan, R., Ernst, M., & Merke, D. P. (2018) · Human Genetics · doi:10.1007/s00439-018-1959-z · Cited by 12
Metadata
- Authors
- Wu, Y. L., Yang, Y., Chung, E. K., Zhou, B., Kitzmiller, K. J., Savelli, S. L., Nagaraja, H. N., Birmingham, D. J., Tsao, B. P., Rovin, B. H., Hebert, L. A., & Yu, C. Y.
- Venue
- Cytogenetic and Genome Research
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 123
- Issue
- 1-4
- Pages
- 131-141
- ISSN
- 1424-859X (ISSN-L)
- 1424-8581
- OpenAlex
- W2144229161
- Cited by
- 64
- References
- 9
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.